TOPO-II PHOSPHORYLATION AND CELL DIFFERENTIATION
TOPO-II PHOSPHORYLATION AND CELL DIFFERENTIATION
批准号:
2390798
负责人:
ANDREAS I. CONSTANTINOU
金额:
$11.63万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-04-01 至 1999-03-31
中文摘要
这项建议的长期研究目标是:a)准确地
定义DNA拓扑异构酶II(Topo II)的活性是如何通过
培养细胞中的磷酸化,以及b)识别特定的
影响细胞生长和分化的磷酸化位点。
初步数据有力地表明Topo II在
多个站点。Topo II磷酸化增加与
在无细胞体系中,酶活性升高;然而,在佛波醇中
酯处理的HL-60细胞,它与活性降低有关。基座
根据这些观察和其他磷酸化/活性关系,
我们假设某些Topo II位点的磷酸化
使这种酶的活性降低,而其他位点的磷酸化
使其更加活跃。仔细研究这一假设,并定义
Topo II磷酸化在培养细胞中的生物学意义
建议:a)绘制Topo II的多个磷酸化位点图;b)
确定蛋白激酶调控的Topo II特异性位点
激活剂和抑制剂,定义它们对催化链的影响
通过)酶的活性;以及c)鉴定特定的Topo II
决定因素,当磷酸化,影响能力的能力
在Topo II反应性抗肿瘤药物存在下连接DNA的酶
探员们。在本项目结束时,预计
对细胞生长和分化的调控将进一步阐明
Topo II和蛋白激酶的相互作用将被记录在案。
英文摘要
The long term research objectives of this proposal are: a) to precisely
define how the activity of DNA topoisomerase II (topo II) is regulated by
phosphorylation in cultured cells, and b) to identify the specific
phosphorylation sites which influence cell growth and differentiation.
Preliminary data strongly suggest that topo II is phosphorylated at
multiple sites. Increased topo II phosphorylation is associated with
elevated enzymatic activity in cell-free systems; however, in phorbol
ester-treated HL-60 cells it is associated with reduced activity. Based
on these observations and other phosphorylation/activity relationships,
we form the hypothesis that phosphorylation of certain topo II sites
renders this enzyme less active, while the phosphorylation of other sites
renders it more active. To scrutinize this hypothesis, and to define the
biological significance of topo II phosphorylation in cultured cells, we
propose to: a) map the multiple phosphorylation sites of topo II; b)
identify the specific topo II sites modulated by protein kinase
activators and inhibitors, define their impact on the catalytic (strand
passing) activity of the enzyme; and c) identify specific topo II
determinants which, when phosphorylated, influence the ability of the
enzyme to ligate DNA in the presence of topo II-reactive antitumor
agents. At the end of this project, it is anticipated that the
regulation of cell growth and differentiation will be further clarified
and the interactions of topo II and protein kinases will be documented.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/s0959-8049(00)00017-4
发表时间:
2000-04
期刊:
European journal of cancer
影响因子:
8.4
作者:
[G. Salti;S. Grewal;R. Mehta;T. K. Das Gupta;A. Boddie;A. Constantinou]
通讯作者:
G. Salti;S. Grewal;R. Mehta;T. K. Das Gupta;A. Boddie;A. Constantinou
Resistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides.
人白血病 HL-60 细胞对依托泊苷的耐药性:与拓扑异构酶 II 磷酸肽低磷酸化相关的药物诱导的 DNA 裂解减少。
DOI:
--
发表时间:
1996
期刊:
Molecular pharmacology.
影响因子:
--
作者:
[Ganapathi,R, Constantinou,A, Kamath,N, Dubyak,G, Grabowski,D, Krivacic,K]
通讯作者:
Krivacic,K
Commitment to erythroid differentiation in mouse erythroleukemia cells is controlled by alterations in topoisomerase II alpha phosphorylation.
小鼠红白血病细胞的红细胞分化是通过拓扑异构酶 II α 磷酸化的改变来控制的。
DOI:
--
发表时间:
1996
期刊:
Cancer research
影响因子:
11.2
作者:
[Constantinou,AI, Vaughan,AT, Yamasaki,H, Kamath,N]
通讯作者:
Kamath,N
A novel use for the comet assay: detection of topoisomerase II inhibitors.
彗星试验的新用途:检测拓扑异构酶 II 抑制剂。
DOI:
--
发表时间:
2000
期刊:
Anticancer research.
影响因子:
--
作者:
[Salti,GI, DasGupta,TK, Constantinou,AI]
通讯作者:
Constantinou,AI
Topologically constrained domains of supercoiled DNA in eukaryotic cells.
真核细胞中超螺旋 DNA 的拓扑约束结构域。
DOI:
10.1089/dna.1997.16.1051
发表时间:
1997
期刊:
DNA and cell biology.
影响因子:
--
作者:
[Khodarev,NN, Narayana,A, Constantinou,A, Vaughan,AT]
通讯作者:
Vaughan,AT
Mechanism(s)of antitumor action of tamoxifen and soy
-
批准号:6411779
-
项目类别:
-
资助金额:$44.02万
-
财政年份:2001
-
负责人:ANDREAS I. CONSTANTINOU
-
依托单位:
Mechanism(s)of antitumor action of tamoxifen and soy
-
批准号:6658979
-
项目类别:
-
资助金额:$45.95万
-
财政年份:2001
-
负责人:ANDREAS I. CONSTANTINOU
-
依托单位:
CHEMOPREVENTION OF MAMMARY TUMORS BY TAMOXIFEN AND SOY
-
批准号:6401157
-
项目类别:
-
资助金额:$7.79万
-
财政年份:2001
-
负责人:ANDREAS I. CONSTANTINOU
-
依托单位:
CHEMOPREVENTION OF MAMMARY TUMORS BY TAMOXIFEN AND SOY
-
批准号:6515233
-
项目类别:
-
资助金额:$7.79万
-
财政年份:2001
-
负责人:ANDREAS I. CONSTANTINOU
-
依托单位:
Mechanism(s)of antitumor action of tamoxifen and soy
-
批准号:6522948
-
项目类别:
-
资助金额:$44.61万
-
财政年份:2001
-
负责人:ANDREAS I. CONSTANTINOU
-
依托单位:
TOPO-II PHOSPHORYLATION AND CELL DIFFERENTIATION
-
批准号:2103252
-
项目类别:
-
资助金额:$10.21万
-
财政年份:1993
-
负责人:ANDREAS I. CONSTANTINOU
-
依托单位:
TOPO-II PHOSPHORYLATION AND CELL DIFFERENTIATION
-
批准号:3460899
-
项目类别:
-
资助金额:$8.26万
-
财政年份:1993
-
负责人:ANDREAS I. CONSTANTINOU
-
依托单位:
TOPO-II PHOSPHORYLATION AND CELL DIFFERENTIATION
-
批准号:2103251
-
项目类别:
-
资助金额:$9.64万
-
财政年份:1993
-
负责人:ANDREAS I. CONSTANTINOU
-
依托单位:
PREVENTION OF MAMMARY CARCINOGENESIS BY QUERCETIN
-
批准号:2097580
-
项目类别:
-
资助金额:$12.68万
-
财政年份:1993
-
负责人:ANDREAS I. CONSTANTINOU
-
依托单位:
TOPO-II PHOSPHORYLATION AND CELL DIFFERENTIATION
-
批准号:2103253
-
项目类别:
-
资助金额:$11.07万
-
财政年份:1993
-
负责人:ANDREAS I. CONSTANTINOU
-
依托单位:
PREVENTION OF MAMMARY CARCINOGENESIS BY QUERCETIN
-
批准号:3201193
-
项目类别:
-
资助金额:$11.33万
-
财政年份:1993
-
负责人:ANDREAS I. CONSTANTINOU
-
依托单位:
PREVENTION OF MAMMARY CARCINOGENESIS BY QUERCETIN
-
批准号:2097581
-
项目类别:
-
资助金额:$13.7万
-
财政年份:1993
-
负责人:ANDREAS I. CONSTANTINOU
-
依托单位:
CYCLIC AMP REGULATION OF LDH GENE EXPRESSION
-
批准号:3040735
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1987
-
负责人:ANDREAS I. CONSTANTINOU
-
依托单位:
CYCLIC AMP REGULATION OF LDH GENE EXPRESSION
-
批准号:3040734
-
项目类别:
-
资助金额:$2.0万
-
财政年份:1986
-
负责人:ANDREAS I. CONSTANTINOU
-
依托单位:
CYCLIC AMP REGULATION OF LDH GENE EXPRESSION
-
批准号:3040733
-
项目类别:
-
资助金额:$1.9万
-
财政年份:1985
-
负责人:ANDREAS I. CONSTANTINOU
-
依托单位:
海外基金